Literature DB >> 11819443

Clarithromycin resistance in Helicobacter pylori and its clinical relevance.

Hua-Xiang Xia, Xue-Gong Fan, Nicholas J Talley.   

Abstract

Entities:  

Year:  1999        PMID： 11819443      PMCID： PMC4688482          DOI： 10.3748/wjg.v5.i3.263

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN： 1007-9327            Impact factor:   5.742


× No keyword cloud information.
  39 in total

Review 1.  Epidemiology and mechanism of antibiotic resistance in Helicobacter pylori.

Authors:  F Mégraud
Journal:  Gastroenterology       Date:  1998-11       Impact factor: 22.682

2.  Point mutations in the 23S rRNA gene of Helicobacter pylori associated with different levels of clarithromycin resistance.

Authors:  J Versalovic; M S Osato; K Spakovsky; M P Dore; R Reddy; G G Stone; D Shortridge; R K Flamm; S K Tanaka; D Y Graham
Journal:  J Antimicrob Chemother       Date:  1997-08       Impact factor: 5.790

3.  [Clarithromycin combined short-term triple therapies for eradication of Helicobacter pylori infection].

Authors:  W Liu; B Lü; S Xiao
Journal:  Zhonghua Nei Ke Za Zhi       Date:  1996-12

Review 4.  Resistance of Helicobacter pylori to antibiotics.

Authors:  F Mégraud
Journal:  Aliment Pharmacol Ther       Date:  1997-04       Impact factor: 8.171

5.  Helicobacter pylori: primary susceptibility to clarithromycin in vitro in Nova Scotia.

Authors:  L M Best; D J Haldane; G S Bezanson; S J Veldhuyzen van Zanten
Journal:  Can J Gastroenterol       Date:  1997 May-Jun       Impact factor: 3.522

6.  Mechanism of clarithromycin resistance in clinical isolates of Helicobacter pylori.

Authors:  Y J Debets-Ossenkopp; M Sparrius; J G Kusters; J J Kolkman; C M Vandenbroucke-Grauls
Journal:  FEMS Microbiol Lett       Date:  1996-08-15       Impact factor: 2.742

7.  Metronidazole- and clarithromycin-resistant Helicobacter pylori in dyspeptic patients in western Sydney as determined by testing multiple isolates from different gastric sites.

Authors:  H H Xia; J Kalantar; N J Talley
Journal:  J Gastroenterol Hepatol       Date:  1998-10       Impact factor: 4.029

8.  Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori.

Authors:  J Versalovic; D Shortridge; K Kibler; M V Griffy; J Beyer; R K Flamm; S K Tanaka; D Y Graham; M F Go
Journal:  Antimicrob Agents Chemother       Date:  1996-02       Impact factor: 5.191

9.  Prevalence of metronidazole-resistant Helicobacter pylori in dyspeptic patients.

Authors:  H X Xia; M A Daw; S Beattie; C T Keane; C A O'Morain
Journal:  Ir J Med Sci       Date:  1993-03       Impact factor: 1.568

10.  Characterization of clinical isolates of Helicobacter pylori in Singapore.

Authors:  J Hua; H C Ng; K G Yeoh; K Y Ho; B Ho
Journal:  Microbios       Date:  1998
View more
  9 in total

Review 1.  Clinical role and importance of fluorescence in situ hybridization method in diagnosis of H pylori infection and determination of clarithromycin resistance in H pylori eradication therapy.

Authors:  Ozlem Yilmaz; Ebru Demiray
Journal:  World J Gastroenterol       Date:  2007-02-07       Impact factor: 5.742

2.  Helicobacter pylori infection in hemodialysis patients: susceptibility to amoxicillin and clarithromycin.

Authors:  Selim Aydemir; Sedat Boyacioglu; Gurden Gur; Muge Demirbilek; Fusun-Kamber Can; Murat Korkmaz; Ugur Yilmaz
Journal:  World J Gastroenterol       Date:  2005-02-14       Impact factor: 5.742

3.  Recombinant Helicobacter pylori catalase.

Authors:  Yang Bai; Ya-Li Zhang; Jian-Feng Jin; Ji-De Wang; Zhao-Shan Zhang; Dian-Yuan Zhou
Journal:  World J Gastroenterol       Date:  2003-05       Impact factor: 5.742

4.  Construction and characterization of bivalent vaccine candidate expressing HspA and M(r)18,000 OMP from Helicobacter pylori.

Authors:  Zheng Jiang; Ai-Long Huang; Xiao-Hong Tao; Pi-Long Wang
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

5.  Comparison of the efficacy of 250 mg and 500 mg clarithromycin used with lansoprazole and amoxicillin in eradication regimens for Helicobacter pylori infection.

Authors:  Josip Bago; Anita Galović; Zeljka Belosić Halle; A Bilić; M Bevanda; Petra Bago
Journal:  Wien Klin Wochenschr       Date:  2004-07-31       Impact factor: 1.704

6.  Prospective cohort study of comprehensive prevention to gastric cancer.

Authors:  Hai-Qiang Guo; Peng Guan; Hai-Long Shi; Xuan Zhang; Bao-Sen Zhou; Yuan Yuan
Journal:  World J Gastroenterol       Date:  2003-03       Impact factor: 5.742

7.  Rapid identification of Helicobacter pylori and assessment of clarithromycin susceptibility from clinical specimens using FISH.

Authors:  Ebru Demiray-Gürbüz; Özlem Yılmaz; Asalia Z Olivares; Can Gönen; Sülen Sarıoğlu; Müjde Soytürk; Sait Tümer; Oğuz Altungöz; İlkay Şimşek; Guillermo I Perez Perez
Journal:  J Pathol Clin Res       Date:  2016-11-26

8.  Isolation of Helicobacter pylori in gastric mucosa and susceptibility to five antimicrobial drugs in Southern chile.

Authors:  Laura Otth; Myra Wilson; Heriberto Fernández; Carola Otth; Claudio Toledo; Victoria Cárcamo; Paula Rivera; Luis Ruiz
Journal:  Braz J Microbiol       Date:  2011-06-01       Impact factor: 2.476

9.  Resistance pattern of Helicobacter pylori strains to clarithromycin, metronidazole, and amoxicillin in Isfahan, Iran.

Authors:  Farzad Khademi; Jamshid Faghri; Farkhondeh Poursina; Bahram Nasr Esfahani; Sharareh Moghim; Hossein Fazeli; Peyman Adibi; Nasrin Mirzaei; Mojtaba Akbari; Hajieh Ghasemian Safaei
Journal:  J Res Med Sci       Date:  2013-12       Impact factor: 1.852
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.